[go: up one dir, main page]

ES2154453T3 - Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones. - Google Patents

Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones.

Info

Publication number
ES2154453T3
ES2154453T3 ES97907154T ES97907154T ES2154453T3 ES 2154453 T3 ES2154453 T3 ES 2154453T3 ES 97907154 T ES97907154 T ES 97907154T ES 97907154 T ES97907154 T ES 97907154T ES 2154453 T3 ES2154453 T3 ES 2154453T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
amidiniums
family
applications
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97907154T
Other languages
English (en)
Inventor
Jean-Marie Lehn
Pierre Lehn
Jean-Pierre Vigneron
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2154453(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9602604A external-priority patent/FR2745569B1/fr
Priority claimed from FR9609557A external-priority patent/FR2751972B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2154453T3 publication Critical patent/ES2154453T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVOS DERIVADOS DE AMIDINIUM DE FORMULA (I), EN LA CUAL: R1 REPRESENTA UN DERIVADO DEL COLESTEROL O UN GRUPO ALQUILO AMINO - NR R ; R2 Y R3 REPRESENTAN, INDEPENDIENTEMENTE UNO DEL OTRO, UN ATOMO DE HIDROGENO O UN GRUPO DE FORMULA (II), EN LA CUAL R4 Y R5 REPRESENTAN, INDEPENDIENTEMENTE UNO DEL OTRO, UN ATOMO DE HIDROGENO O UN GRUPO DE FORMULA (III). LA PRESENTE INVENCION SE REFIERE ADEMAS A LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN, APLICABLES EN PARTICULAR EN TERAPIA GENICA PARA LA TRANSFERENCIA DE GENES TERAPEUTICOS A LAS CELULAS.
ES97907154T 1996-03-01 1997-02-28 Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones. Expired - Lifetime ES2154453T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602604A FR2745569B1 (fr) 1996-03-01 1996-03-01 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications
FR9609557A FR2751972B1 (fr) 1996-07-30 1996-07-30 Composes apparentes a la famille des amidiniums, compositions pharmaceutiques les contenant et leurs applications

Publications (1)

Publication Number Publication Date
ES2154453T3 true ES2154453T3 (es) 2001-04-01

Family

ID=26232562

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97907154T Expired - Lifetime ES2154453T3 (es) 1996-03-01 1997-02-28 Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones.

Country Status (18)

Country Link
US (2) US6143729A (es)
EP (1) EP0888379B1 (es)
JP (1) JP4271260B2 (es)
KR (1) KR19990087372A (es)
AT (1) ATE198599T1 (es)
AU (1) AU723998B2 (es)
BR (1) BRPI9707889B8 (es)
CZ (1) CZ295225B6 (es)
DE (1) DE69703878T2 (es)
DK (1) DK0888379T3 (es)
ES (1) ES2154453T3 (es)
GR (1) GR3035205T3 (es)
HU (1) HU228072B1 (es)
IL (1) IL125926A (es)
NO (1) NO311806B1 (es)
PT (1) PT888379E (es)
SK (1) SK283575B6 (es)
WO (1) WO1997031935A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884430B1 (en) 1997-02-10 2005-04-26 Aventis Pharma S.A. Formulation of stabilized cationic transfection agent(s) /nucleic acid particles
FR2763943B1 (fr) * 1997-05-28 1999-07-09 Rhone Poulenc Rorer Sa Composes, leur preparation et leur utilisation pour le transfert d'acides nucleiques dans les cellules
CA2324931A1 (fr) * 1998-04-02 1999-10-14 Aventis Pharma S.A. Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
FR2777017B1 (fr) * 1998-04-02 2002-08-23 Rhone Poulenc Rorer Sa Nouveaux agents de transfert d'acides nucleiques, compositions les contenant et leurs applications
DE10109898A1 (de) 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
FR2824557B1 (fr) * 2001-05-14 2003-08-29 Aventis Pharma Sa Derives lipidiques de polythiouree
JP4276439B2 (ja) * 2001-05-14 2009-06-10 サントリオン ポリチオ尿素の脂質誘導体
FR2829136B1 (fr) 2001-08-29 2006-11-17 Aventis Pharma Sa Derives lipidiques d'aminoglycosides
PT1479985T (pt) 2002-01-17 2017-08-03 Alfa Laval Corp Ab Evaporador submerso compreendendo um permutador de calor de placas e um compartimento cilíndrico onde está disposto o permutador de calor de placas
JP4980893B2 (ja) * 2005-04-28 2012-07-18 日本曹達株式会社 新規なグアニジン化合物、製造方法及びそれらを含有する殺菌性組成物
JP5407862B2 (ja) * 2006-10-04 2014-02-05 サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィーク（セーエヌエールエス） ｓｉＲＮＡおよび脂質性４，５−二置換２−デオキシストレプタミン環アミノグリコシド誘導体を含む組成物ならびにその用途
CN102216462A (zh) * 2008-11-17 2011-10-12 安龙制药公司 用于核酸递送系统的支化阳离子脂质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
CA2176715A1 (en) * 1993-11-24 1995-06-01 Timothy D. Heath Amphiphilic derivatives of guanidine
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6071890A (en) * 1994-12-09 2000-06-06 Genzyme Corporation Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes

Also Published As

Publication number Publication date
IL125926A (en) 2004-09-27
BR9707889A (pt) 2000-01-04
HUP9902465A3 (en) 2009-10-28
WO1997031935A1 (fr) 1997-09-04
NO983691L (no) 1998-08-12
DE69703878T2 (de) 2001-04-26
SK118298A3 (en) 1999-02-11
PT888379E (pt) 2001-05-31
KR19990087372A (ko) 1999-12-27
KR100452062B1 (es) 2005-04-08
AU723998B2 (en) 2000-09-07
JP4271260B2 (ja) 2009-06-03
BR9707889B1 (pt) 2010-03-23
DE69703878D1 (de) 2001-02-15
HUP9902465A1 (hu) 1999-12-28
EP0888379B1 (fr) 2001-01-10
JP2000506136A (ja) 2000-05-23
NO983691D0 (no) 1998-08-12
IL125926A0 (en) 1999-04-11
DK0888379T3 (da) 2001-01-29
BRPI9707889B8 (pt) 2016-11-08
CZ277298A3 (cs) 1998-12-16
AU1930497A (en) 1997-09-16
US6316422B1 (en) 2001-11-13
GR3035205T3 (en) 2001-04-30
EP0888379A1 (fr) 1999-01-07
NO311806B1 (no) 2002-01-28
HU228072B1 (en) 2012-09-28
ATE198599T1 (de) 2001-01-15
US6143729A (en) 2000-11-07
SK283575B6 (sk) 2003-09-11
CZ295225B6 (cs) 2005-06-15

Similar Documents

Publication Publication Date Title
ES2154453T3 (es) Compuestos pertenecientes a la familia de los amidiniums, composiciones farmaceuticas que les contienen y sus aplicaciones.
CO4810373A1 (es) Compuestos azapoliciclicos condensados con arilo
BR0014144A (pt) Derivados de n-heterocìclicos como inibidores de nos
CO4650042A1 (es) Derivados de 6-fenilpiridil-2-amina
ES2040276T3 (es) Derivados de la indolizina, procedimiento para su preparacion y composiciones que los contienen.
ES2190396T3 (es) Nuevos compuestos amino-triazoles, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
BRPI0509364B8 (pt) derivados de tetraidroquinolina, composição farmacêutica que os compreende e um processo por preparar os referidos derivados
UY24555A1 (es) Nuevos compuestos
DK0968206T3 (da) N-heterocykliske derivater som NOS-inhibitorer
ES2188194T3 (es) 1,8-naftiridin-4(1h)-onas sustituidas como inhibidores de la fosfodiesterasa 4.
HUP0000762A2 (hu) 2-Amino-6-(2-szubsztituált-4-fenoxi)piridin-származékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
CO4840509A1 (es) 2,4 diaminopirimidinas sustituidas, medicamento que contiene dichos compuestos para el control o la prevencion de enfermedades infecciosas y procedimiento para la preparacion de dichos compuestos"
FI803264L (fi) 2-hydroxialkyl-3,4,5-trihydroxipiperidiner foerfarande foer framstaellning av dem och anvaendning av dem som laekemedel
MY117687A (en) Substituted 4-biphenyl-4-hydroxybutric acid derivatives as matrix metalloprotease inhibitors
NO158578C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.
BR9916669A (pt) Uso de derivados de ácidos 4-biarilbutìricos e 5-biarilpentanóicos substituìdos como inibidores de metaloproteases de matriz para o tratamento de doenças respiratórias
SE8107387L (sv) Nya fenylalkylaminer, framstellning derav och anvendning som lekemedel
ES2032752T3 (es) Procedimiento de preparacion de derivados de la 1-bencenosulfonil-2-oxo-5-alcoxi-pirrolidina.
AR010098A1 (es) COMPOSICION Y PROCEDIMIENTO PARA LA DEFORMACION PERMANENTE DEL CABELLO, Y PROCEDIMIENTO DE PREPARACIoN DE DICHA COMPOSICION
ES2125963T3 (es) Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
ES2172376B1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0937043T3 (da) Substituerede tetrahydropyridin-derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse derivater
AR010107A1 (es) Compuestos analogos a la talidomida de la clase de las piperidin-2,6-dionas, procedimiento para su preparacion y su aplicacion en medicamentos
CR6503A (es) Derivados de- 1-trifluorometil-4-hidroxi-7-piperidinil-aminometiclcromano
NO864665L (no) Nye basisk substituerte pyridinforbindelser, fremgangsmaate til deres fremstilling, legemidler inneholdende dem, og deres anvendelse.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 888379

Country of ref document: ES